pART i O verview We are a clinical-stage biotechnology company that was incorporated under the laws of the State of Delaware in February 2005. We are focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. We believe that our strategy combines many of the cost efficiencies and risk abatements derived from using existing generic drugs with potential patent protections for our proprietary formulations; t...
Q2 FY2026 — expected 2026-09-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-28 | 2024-12-31 | 0001753926-25-000507 | EDGAR | 79K words |
| 2024-02-27 | 2023-12-31 | 0001753926-24-000403 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001753926-23-000352 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001753926-25-001805 | EDGAR | 23K words |
| 2025-08-14 | 2025-06-30 | 0001753926-25-001347 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001753926-25-000818 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001753926-24-001927 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001753926-24-001419 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001753926-24-000943 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001753926-23-001484 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001753926-23-001052 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001753926-23-000649 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-15 | 0001753926-26-001173 | EDGAR | — |
| 2026-03-31 | 0001753926-26-000577 | EDGAR | 1K words |
| 2026-02-04 | 0001753926-26-000265 | EDGAR | — |
| 2025-10-21 | 0001753926-25-001636 | EDGAR | — |
| 2025-10-09 | 0001753926-25-001602 | EDGAR | — |
| 2025-09-18 | 0001753926-25-001525 | EDGAR | — |
| 2025-06-25 | 0001753926-25-001003 | EDGAR | — |
| 2025-06-20 | 0001753926-25-000984 | EDGAR | — |
| 2025-06-16 | 0001753926-25-000962 | EDGAR | — |
| 2025-05-16 | 0001753926-25-000856 | EDGAR | — |
77 total filings indexed. 55 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001347242 |
| Ticker | LIPO |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/LIPO (~200 tokens, structured JSON with cryptographic provenance)